Loading organizations...
Cell Rising Capital is a Hong Kong-based venture capital firm providing angel to Series A funding for startups across Europe and Asia. The firm strategically invests in companies developing cutting-edge technologies, with a strong emphasis on artificial intelligence. Their core approach identifies nascent enterprises with high growth potential in these specialized sectors.
Founded in 2020, Cell Rising Capital was established with the insight that early-stage technological ventures require dedicated capital and strategic support. This commitment drives the firm to empower pioneering solutions from nascent stages. The foundation lies in nurturing promising startups with innovative core offerings.
The firm's portfolio primarily consists of innovative startups within artificial intelligence and broader emerging technology domains. Cell Rising Capital's vision centers on enhancing business sustainability through continuous innovation, actively seeking companies poised to drive meaningful change. Their long-term outlook aims to cultivate a robust ecosystem of advanced, sustainable enterprises.
Cell Rising Capital has 3 tracked investments across 2 companies. The latest tracked deal is $10.0M Other Equity in Hex Trust in October 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 5, 2021 | Hex Trust | $10.0M Other Equity | Animoca Brands | Algorand Foundation, BCW Group, Borderless Capital, Double Peak, Alessio Quaglini, Kenetic Capital, Mantra DAO, Mind Fund, QBN Capital, Radiant Tech Ventures, Ripple, Tessera Capital Partners, Token BAY Capital |
| May 17, 2021 | Wrisk | $6.5M Series A | Philea Chim | Malcolm King |
| Mar 31, 2021 | Hex Trust | $6.0M Series A | Frank Tong | Henri Arslanian, Borderless Capital, Fenbushi Capital, GBV Capital, HashKey Capital, Jehan CHU, MD Labs, Radiant Tech Ventures |
